Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017 (2017), Article ID 1702967, 11 pages
https://doi.org/10.1155/2017/1702967
Research Article

The Hepatoprotective and MicroRNAs Downregulatory Effects of Crocin Following Hepatic Ischemia-Reperfusion Injury in Rats

1Physiology Research Center (PRC), Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2Physiology Research Center (PRC), Research Center for Infectious Diseases of Digestive System, Department of Physiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3Cellular and Molecular Research Center, Department of Anatomical Sciences, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Correspondence should be addressed to Seyyed Ali Mard; ri.ca.smuja@as-dram

Received 27 September 2016; Revised 16 January 2017; Accepted 31 January 2017; Published 6 March 2017

Academic Editor: Kum Kum Khanna

Copyright © 2017 Ghaidafeh Akbari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. C. Teoh and G. C. Farrell, “Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection,” Journal of Gastroenterology and Hepatology, vol. 18, no. 8, pp. 891–902, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. E. A. Khowailed, H. A. Mubarak, H. A. Seddeek et al., “Protectiv xanthine oxidase inhibition on ischemia/reperfusion injury in rat liver,” The Medical Journal of Cairo University, vol. 79, no. 2, pp. 667–677, 2011. View at Google Scholar
  3. J. R. Klune and A. Tsung, “Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements,” Surgical Clinics of North America, vol. 90, no. 4, pp. 665–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Bernardi, U. Soffientini, F. Piacente, and M. G. Tonetti, “Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells,” PLOS ONE, vol. 8, no. 10, Article ID e76540, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Li, J. Zhu, H. Fu et al., “Hepato-specific microRNA-122 facilitates accumulation of newly synthesized miRNA through regulating PRKRA,” Nucleic Acids Research, vol. 40, no. 2, pp. 884–891, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. E. Erson and E. M. Petty, “MicroRNAs in development and disease,” Clinical Genetics, vol. 74, no. 4, pp. 296–306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Chang, E. Nicolas, D. Marks et al., “miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and maydownregulate the high affinity cationic amino acid transporter CAT-1,” RNA Biology, vol. 1, no. 2, pp. 106–113, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Castoldi, M. V. Spasic, S. Altamura et al., “The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice,” Journal of Clinical Investigation, vol. 121, no. 4, pp. 1386–1396, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Fornari, L. Gramantieri, C. Giovannini et al., “MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells,” Cancer Research, vol. 69, no. 14, pp. 5761–5767, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Siaj, V. Sauer, S. Stöppeler et al., “Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease,” Hepatology International, vol. 6, no. 4, pp. 770–777, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Caster, T. Brandenburger, T. Strahl et al., “Circulating microRNA-122, -21 and -223 as potential markers of liver injury following warm ischaemia and reperfusion in rats,” Molecular Medicine Reports, vol. 12, no. 2, pp. 3146–3150, 2015. View at Publisher · View at Google Scholar
  12. M. P. Parikh, A. M. Patel, K. V. Ptel et al., “Protective effect of Momordica charantia against hepatic ischemic reperfusion injury model in rats,” Austin Journal of Pharmacology and Therapeutics, vol. 3, no. 1, p. 1064, 2015. View at Google Scholar
  13. C. Jalili, H. Tabatabaei, S. Kakaberiei, S. Roshankhah, and M. R. Salahshoor, “Protective role of crocin against nicotine-induced damages on male mice liver,” International Journal of Preventive Medicine, vol. 6, no. 1, p. 92, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. O. F. Laterza, M. G. Scott, P. W. Garrett-Engele, K. M. Korenblat, and C. M. Lockwood, “Circulating miR-122 as a potential biomarker of liver disease,” Biomarkers in Medicine, vol. 7, no. 2, pp. 205–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Shifeng, W. Danni, C. Pu, Y. Ping, C. Ju, and Z. Liping, “Circulating liver-specific mir-122 as a novel potential biomarker for diagnosis of cholestatic liver injury,” PLoS ONE, vol. 8, no. 9, Article ID e73133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Cermelli, A. Ruggieri, J. A. Marrero, G. N. Ioannou, and L. Beretta, “Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease,” PLoS ONE, vol. 6, no. 8, Article ID e23937, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Rokavec, H. Li, L. Jiang, and H. Hermeking, “The p53/miR-34 axis in development and disease,” Journal of Molecular Cell Biology, vol. 6, no. 3, pp. 214–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Mcdaniel, L. Herrera, T. Zhou et al., “The functional role of microRNAs in alcoholic liver injury,” Journal of Cellular and Molecular Medicine, vol. 18, no. 2, pp. 197–207, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. B. C. Bernardo, X.-M. Gao, C. E. Winbanks et al., “Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 43, pp. 17615–17620, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Xu, M. Zalzala, J. Xu, Y. Li, L. Yin, and Y. Zhang, “A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism,” Nature Communications, vol. 6, article 7466, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Zeng, C.-L. Zhang, F.-Y. Song et al., “The activation of HO-1/Nrf-2 contributes to the protective effects of diallyl disulfide (DADS) against ethanol-induced oxidative stress,” Biochimica et Biophysica Acta - General Subjects, vol. 1830, no. 10, pp. 4848–4859, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Wang, J. Yao, Z. Li et al., “MiR-34a-5p inhibition alleviates intestinal ischemia/reperfusion-induced reactive oxygen species accumulation and apoptosis via activation of SIRT1 signaling,” Antioxidants and Redox Signaling, vol. 24, no. 17, pp. 961–973, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. R. De Paola, C. Muià, E. Mazzon et al., “Effects of Hypericum perforatum extract in a rat model of ischemia and reperfusion injury,” Shock, vol. 24, no. 3, pp. 255–263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Sun, J. Yang, L.-Z. Wang, L.-R. Sun, and Q. Dong, “Crocin attenuates cisplatin-induced liver injury in the mice,” Human and Experimental Toxicology, vol. 33, no. 8, pp. 855–862, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Yabe, N. Kobayashi, T. Nishihashi et al., “Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives,” Journal of Pharmacology and Experimental Therapeutics, vol. 298, no. 3, pp. 894–899, 2001. View at Google Scholar · View at Scopus
  26. H. E. Poulsen, E. Specht, K. Broedbaek et al., “RNA modifications by oxidation: a novel disease mechanism?” Free Radical Biology and Medicine, vol. 52, no. 8, pp. 1353–1361, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Hassler, S. S. Cao, and R. J. Kaufman, “IRE1, a Double-Edged Sword in Pre-miRNA Slicing and Cell Death,” Developmental Cell, vol. 23, no. 5, pp. 921–923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-P. Upton, L. Wang, D. Han et al., “IRE1α cleaves select microRNAs during ER stress to derepress translation of proapoptotic Caspase-2,” Science, vol. 338, no. 6108, pp. 818–822, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Ling and Z. Wei-Guo, “p53: structure, function and therapeutic applications,” Journal of Cancer Molecules, vol. 2, no. 4, pp. 141–153, 2006. View at Google Scholar
  30. K. H. Vousden and X. Lu, “Live or let die: the cell's response to p53,” Nature Reviews Cancer, vol. 2, no. 8, pp. 594–604, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Derdak, K. A. Villegas, R. Harb, A. M. Wu, A. Sousa, and J. R. Wands, “Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, no. 4, pp. 785–791, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Wei, J. Gong, T. Yoshida et al., “Nrf2 has a protective role against neuronal and capillary degeneration in retinal ischemia-reperfusion injury,” Free Radical Biology and Medicine, vol. 51, no. 1, pp. 216–224, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. D. Klaassen and S. A. Reisman, “Nrf2 the rescue: effects of the antioxidative/electrophilic response on the liver,” Toxicology and Applied Pharmacology, vol. 244, no. 1, pp. 57–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. S. A. Reisman, I. I. Csanaky, L. M. Aleksunes, and C. D. Klaassen, “Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice,” Toxicological Sciences, vol. 109, no. 1, pp. 31–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Xu, J. Weerachayaphorn, S.-Y. Cai, C. J. Soroka, and J. L. Boyer, “Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 299, no. 1, pp. G126–G135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Tang, Y.-F. Jiang, M. Ponnusamy, and M. Diallo, “Role of Nrf2 in chronic liver disease,” World Journal of Gastroenterology, vol. 20, no. 36, pp. 13079–13087, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. I. M. Copple, C. E. Goldring, N. R. Kitteringham, and B. K. Park, “The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity,” Toxicology, vol. 246, no. 1, pp. 24–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. P. Angulo, “Nonalcoholic fatty liver disease,” New England Journal of Medicine, vol. 346, no. 16, pp. 1221–1231, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. F. I. Abdullaev, “Biological effects of saffron,” BioFactors, vol. 4, no. 2, pp. 83–86, 1993. View at Google Scholar · View at Scopus
  40. S. A. Mard, M. H. Pipelzadeh, A. Teimoori et al., “Protective activity of crocin against indomethacin-induced gastric lesions in rats,” Journal of Natural Medicines, vol. 70, no. 1, pp. 62–74, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Arda-Pirincci, S. Bolkent, and R. Yanardag, “The role of zinc sulfate and metallothionein in protection against ethanol-induced gastric damage in rats,” Digestive Diseases and Sciences, vol. 51, no. 12, pp. 2353–2360, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Mard, Z. Nikraftar, Y. Farbood, and E. Mansouri, “A preliminary study of the anti-inflammatory and anti-apoptotic effects of crocin against gastric ischemia-reperfusion injury in rats,” Brazilian Journal of Pharmaceutical Sciences, vol. 51, no. 3, pp. 637–642, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Qi, L. Chen, L. Zhang, W.-B. Liu, X.-Y. Chen, and X.-G. Yang, “Crocin prevents retinal ischaemia/reperfusion injury-induced apoptosis in retinal ganglion cells through the PI3K/AKT signalling pathway,” Experimental Eye Research, vol. 107, pp. 44–51, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. Y.-Q. Zheng, J.-X. Liu, J.-N. Wang, and L. Xu, “Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia,” Brain Research, vol. 1138, no. 1, pp. 86–94, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Naghizadeh, M. T. Boroushaki, N. Vahdati Mashhadian, and S. M. T. Mansouri, “Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats,” Iranian Biomedical Journal, vol. 12, no. 2, pp. 93–100, 2008. View at Google Scholar · View at Scopus
  46. B. Naghizadeh, S. M. T. Mansouri, and N. V. Mashhadian, “Crocin attenuates cisplatin-induced renal oxidative stress in rats,” Food and Chemical Toxicology, vol. 48, no. 10, pp. 2650–2655, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Askaripour, S. R. F. Tabatabaei, and F. Hosseini, “Effects of aqueous extract of purslane (Portulaca oleracea) on hepatic enzymes in two models of renal ischemia-reperfusion injury in rats,” Zahedan Journal of Research in Medical Sciences, vol. 18, no. 2, Article ID e5995, 2015. View at Publisher · View at Google Scholar
  48. J. A. Goss, P. Seu, F. Q. Gao, and S. Wyllie, “Ischemia-reperfusion of rat liver modulates hepcidin in vivo expression,” Liver Transplantation, vol. 11, no. 7, pp. 800–806, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. H. T. Lee, S. W. Park, M. Kim, and V. D. D'Agati, “Acute kidney injury after hepatic ischemia and reperfusion injury in mice,” Laboratory Investigation, vol. 89, no. 2, pp. 196–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. A. A. Shokeir, N. Barakat, A. M. Hussein et al., “Activation of Nrf2 by ischemic preconditioning and sulforaphane in renal ischemia/reperfusion injury: a comparative experimental study,” Physiological Research, vol. 64, no. 3, pp. 313–323, 2015. View at Google Scholar · View at Scopus
  51. W. R. R. Farid, Q. Pan, A. J. P. van der Meer et al., “Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation,” Liver Transplantation, vol. 18, no. 3, pp. 290–297, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. A. G. Bader, “miR-34—a microRNA replacement therapy is headed to the clinic,” Frontiers in Genetics, vol. 3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. N. Li, S. Muthusamy, R. Liang, H. Sarojini, and E. Wang, “Increased expression of miR-34a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1,” Mechanisms of Ageing and Development, vol. 132, no. 3, pp. 75–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. X. Huang, Y. Gao, J. Qin, and S. Lu, “The role of miR-34a in the hepatoprotective effect of hydrogen sulfide on ischemia/reperfusion injury in young and old rats,” PLOS ONE, vol. 9, no. 11, Article ID e113305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Thulasingam, C. Massilamany, A. Gangaplara et al., “miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells,” Molecular and Cellular Biochemistry, vol. 352, no. 1-2, pp. 181–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. J. He and B. H. Jiang, “Interplay between reactive oxygen species and MicroRNAs in cancer,” Current Pharmacology Reports, vol. 2, no. 2, pp. 82–90, 2016. View at Publisher · View at Google Scholar
  57. W. Zhang, M. Wang, H. Y. Xie et al., “Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation,” Transplantation Proceedings, vol. 39, no. 5, pp. 1332–1337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. S. H. Kim, J. M. Lee, S. C. Kim, C. B. Park, and P. C. Lee, “Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines,” Biochemistry and Cell Biology, vol. 92, no. 2, pp. 105–111, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. S. A. Mard, S. M. Azad, and A. Ahangarpoor, “Protective effect of crocin on gastric mucosal lesions induced by ischemia-reperfusion injury in rats,” Iranian Journal of Pharmaceutical Research, vol. 15, pp. 93–99, 2016. View at Google Scholar · View at Scopus
  60. R. E. Castro, D. M. S. Ferreira, M. B. Afonso et al., “miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 58, no. 1, pp. 119–125, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Hau, P. Ceppi, and M. E. Peter, “CD95 is part of a let-7/p53/miR-34 regulatory network,” PLoS ONE, vol. 7, no. 11, Article ID e49636, 2012. View at Publisher · View at Google Scholar · View at Scopus
  62. T.-C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Shan, L. Gao, W. Zeng et al., “Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of MIR-34a protects rats against nonalcoholic fatty liver disease,” Cell Death and Disease, vol. 6, no. 7, Article ID e1833, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. C. Abderrahim, “miR-34a-5p and miR-34a-3p contribute to the signaling pathway of p53 by targeting overlapping sets of genes,” https://arxiv.org/abs/1608.02756.
  65. Z. Feng, C. Zhang, R. Wu, and W. Hu, “Tumor suppressor p53 meets microRNAs,” Journal of Molecular Cell Biology, vol. 3, no. 1, pp. 44–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Sözen, M. Kisakürek, F. Yildiz, M. Gönültas, and A. S. Dinçel, “The effects of glutamine on hepatic ischemia reperfusion injury in rats,” Hippokratia, vol. 15, no. 2, pp. 161–166, 2011. View at Google Scholar · View at Scopus
  67. M. Basbug, M. Yildar, I. Yaman et al., “Effects of boric acid in an experimental rat model of hepatic ischemia-reperfusion injury,” Acta Medica Mediterranea, vol. 31, no. 5, pp. 1067–1073, 2015. View at Google Scholar · View at Scopus
  68. Y.-W. Su, X. Chen, Z.-Z. Jiang et al., “A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats,” PLoS ONE, vol. 7, no. 5, Article ID e37395, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Kodama, T. Takehara, H. Hikita et al., “Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice,” Journal of Clinical Investigation, vol. 121, no. 8, pp. 3343–3356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Palipoch and C. Punsawad, “Biochemical and histological study of rat liver and kidney injury induced by cisplatin,” Journal of Toxicologic Pathology, vol. 26, no. 3, pp. 293–299, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. H. I. Suzuki, K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono, “Modulation of microRNA processing by p53,” Nature, vol. 460, no. 7254, pp. 529–533, 2009. View at Publisher · View at Google Scholar · View at Scopus